Impact of Tobacco on Chronic Diseases and Coping Strategies

Authors

  • Jiabaoyi Yang

DOI:

https://doi.org/10.54097/9k3q9f90

Keywords:

Tobacco; chronic diseases; strategies; health impact pyramid.

Abstract

People's physical and mental health are affected by chronic diseases in varied degrees, including chronic lung diseases, cardiovascular disorders, and metabolic diseases. Chronic conditions that are not controlled and are left untreated for an extended length of time can result in psychological issues including mood disorders and place an increased strain on families and society. Finding the appropriate intervention targets and understanding the disease's pathogenic causes and mechanisms are now major concerns for society. With more study, it may become clear that tobacco smoking or the air pollution it produces are directly responsible for the development and progression of chronic diseases. In order to help people better understand the relationship between tobacco use and chronic diseases and to identify and treat them at an early stage, this paper describes the effects of tobacco use and air pollution on various chronic diseases and their correlation with emotions. It also describes the corresponding interventions and preventive measures in accordance with the principle of the health impact pyramid.

Downloads

Download data is not yet available.

References

Wei Mingli. Pulmonary Function Tests and Chronic Obstructive Pulmonary Disease. Health clinic, 2023, 238(04):48-49.

Ren Fengjuan, Xiong Yan. Improve Lung Function, avoid Chronic Obstructive Pulmonary Disease. Health for All, 2023, 596(12):29.

Fang Liwen, Bao Heling, Wang Linhong. The Lancet: Prevalence of chronic obstructive pulmonary disease (COPD) among people over 40 years old in China reaches 13.6 percent. Health Home, 2018, (07):4-6.

Halbert R J, Natoli J L, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. European Respiratory Journal, 2006, 28(3):523-532.

Wheaton A G, Liu Y, Croft J B, et al. Chronic obstructive pulmonary disease and smoking status—United States, 2017. Morbidity and Mortality Weekly Report, 2019, 68(24): 533.

Karimi A, Razaghi R. The role of smoking on the mechanical properties of the human lung[J]. Technology and Health Care, 2018, 26(6): 963-972.

Nathan C, Ding A. Nonresolving inflammation. Cell, 2010, 140(6): 871-882.

Li Zongjie, Di Di, Li Beibei. Interrelationship between lung flora and respiratory diseases. Biotechnology Bulletin, 2020, 36(02): 188-192.

Li Naijian. Effects of atmospheric particulate matter exposure on pulmonary and intestinal microecology in rats and its relation to chronic obstructive pulmonary-like pathological changes. Guangzhou: Guangzhou Medical University, 2018.

Ge Junbo, Xu Yongjian, Wang Chen. Human health internal medicine. Ninth Edition. People's Health Publishing House, Beijing, 19, 2018.

Pelkonen M K, Laatikainen T K, Jousilahti P. The relation of environmental tobacco smoke (ETS) to chronic bronchitis and mortality over two decades. Respiratory Medicine, 2019, 154: 34-39.

Xian Ping, Yan Mengfan, Li Yaoyan, et al. A retrospective cohort study of long-term PM 10 exposure and the risk of chronic bronchitis in urban residents in northern China. Environmental and Occupational Medicine, 2020, 37(2): 95-102.

Lei Wenhui. Analysis of the association between smoking status and risk of cardiovascular disease in middle-aged and elderly men. Wuhan: Huazhong University of Science and Technology, 2019.

Balhara Y P S. Tobacco and metabolic syndrome[J]. Indian journal of endocrinology and metabolism, 2012, 16(1): 81.

Ambrose J A, Barua R S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. Journal of the American college of cardiology, 2004, 43(10): 1731-1737.

Khoramdad M, Vahedian‐azimi A, Karimi L, et al. Association between passive smoking and cardiovascular disease: A systematic review and meta‐analysis. IUBMB life, 2020, 72(4): 677-686.

Chiolero A, Faeh D, Paccaud F, et al. Consequences of smoking for body weight, body fat distribution, and insulin resistance. The American journal of clinical nutrition, 2008, 87(4): 801-809.

Kondo T, Nakano Y, Adachi S, et al. Effects of tobacco smoking on cardiovascular disease. Circulation Journal, 2019, 83(10): 1980-1985.

Quattrocki E, Baird A, Yurgelun-Todd D. Biological aspects of the link between smoking and depression. Harvard review of psychiatry, 2000, 8(3): 99-110.

Fluharty M, Taylor A E, Grabski M, et al. The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine & Tobacco Research, 2016, 19(1): 3-13.

Chen Junxi, Wang Jiamei, Song Qinfeng, et al. A study on the association between passive smoking in pregnant women and depression in early pregnancy. Chinese Journal of Reproductive Health, 2021, 32(04):301-305+323.

Frieden T R. The future of public health. New England Journal of Medicine, 2015, 373(18): 1748-1754.

Pang Dongmei, Hu Xiao. Analysis of the effect of clinical pharmacist intervention on improving medication adherence in patients with chronic obstructive pulmonary disease using inhaled medications. Wisdom Health, 2022, v.8(22): 122-125.

Downloads

Published

29-12-2023

How to Cite

Yang, J. (2023). Impact of Tobacco on Chronic Diseases and Coping Strategies. Highlights in Science, Engineering and Technology, 74, 428-434. https://doi.org/10.54097/9k3q9f90